Development of vaccines for Candida albicans: fighting a skilled transformer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of vaccines for Candida albicans: fighting a skilled transformer
Authors
Keywords
-
Journal
NATURE REVIEWS MICROBIOLOGY
Volume 11, Issue 12, Pages 884-891
Publisher
Springer Nature
Online
2013-11-15
DOI
10.1038/nrmicro3156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvanticity of a Recombinant Calreticulin Fragment in Assisting Anti-β-Glucan IgG Responses in T Cell-Deficient Mice
- (2013) Wei-Ji Li et al. Clinical and Vaccine Immunology
- Enhanced Immunogenicity of a Tricomponent Mannan Tetanus Toxoid Conjugate Vaccine Targeted to Dendritic Cells via Dectin-1 by Incorporating -Glucan
- (2013) T. Lipinski et al. JOURNAL OF IMMUNOLOGY
- Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States
- (2013) Betsy Foxman et al. Journal of Lower Genital Tract Disease
- Candida and candidiasis in HIV-infected patients
- (2012) Antonio Cassone et al. AIDS
- Comparison of two Candida mannan vaccines: The role of complement in protection against disseminated candidiasis
- (2012) Yongmoon Han et al. ARCHIVES OF PHARMACAL RESEARCH
- Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype
- (2012) Chiara Calugi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Designing a new antifungal glycoconjugate vaccine
- (2012) Margaret A. Johnson et al. CHEMICAL SOCIETY REVIEWS
- Immunity to fungi
- (2012) Salomé LeibundGut-Landmann et al. CURRENT OPINION IN IMMUNOLOGY
- Recent progress in vaccines against fungal diseases
- (2012) Antonio Cassone et al. CURRENT OPINION IN MICROBIOLOGY
- The changing epidemiology of healthcare-associated candidemia over three decades
- (2012) Daniel Diekema et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Secreted aspartic proteases ofCandida albicansactivate the NLRP3 inflammasome
- (2012) Donatella Pietrella et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interplay between Candida albicans and the Mammalian Innate Host Defense
- (2012) Shih-Chin Cheng et al. INFECTION AND IMMUNITY
- Glycerol-3-Phosphate Dehydrogenase 2 Is a Novel Factor H–, Factor H–like Protein 1–, and Plasminogen-Binding Surface Protein of Candida albicans
- (2012) Shanshan Luo et al. JOURNAL OF INFECTIOUS DISEASES
- Fungal cell wall vaccines: an update
- (2012) J. E. Edwards JOURNAL OF MEDICAL MICROBIOLOGY
- Self-Adjuvanting Glycopeptide Conjugate Vaccine against Disseminated Candidiasis
- (2012) Hong Xin et al. PLoS One
- A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models
- (2012) Flavia De Bernardis et al. VACCINE
- Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice
- (2012) Ejaj Ahmad et al. VACCINE
- NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
- (2012) Clint S. Schmidt et al. VACCINE
- Sensing of mammalian IL-17A regulates fungal adaptation and virulence
- (2012) Teresa Zelante et al. Nature Communications
- Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4+ T Cells
- (2012) Som Gowda Nanjappa et al. PLoS Pathogens
- Host Defense Pathways Against Fungi: The Basis for Vaccines and Immunotherapy
- (2012) Agostinho Carvalho et al. Frontiers in Microbiology
- A mass spectrometric view of the fungal wall proteome
- (2011) Frans M Klis et al. Future Microbiology
- IL-17 signaling in host defense against Candida albicans
- (2011) Sarah L. Gaffen et al. IMMUNOLOGIC RESEARCH
- Vaccine Immunity to Coccidioidomycosis Occurs by Early Activation of Three Signal Pathways of T Helper Cell Response (Th1, Th2, and Th17)
- (2011) Chiung-Yu Hung et al. INFECTION AND IMMUNITY
- Identification of virulence determinants of the human pathogenic fungi Aspergillus fumigatus and Candida albicans by proteomics
- (2011) Olaf Kniemeyer et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans
- (2011) Wataru Aoki et al. JOURNAL OF BIOCHEMISTRY
- Candida albicans Hgt1p, a Multifunctional Evasion Molecule: Complement Inhibitor, CR3 Analogue, and Human Immunodeficiency Virus–Binding Molecule
- (2011) Iwona Lesiak-Markowicz et al. JOURNAL OF INFECTIOUS DISEASES
- Horizontal Transmission of Candida albicans and Evidence of a Vaccine Response in Mice Colonized with the Fungus
- (2011) Jim E. Cutler et al. PLoS One
- Structural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicans
- (2011) P. S. Salgado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune responses induced by heat killed Saccharomyces cerevisiae: A vaccine against fungal infection
- (2011) Min Liu et al. VACCINE
- Epidemiology of Invasive Mycoses in North America
- (2010) Michael A. Pfaller et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Candida albicans Als3, a Multifunctional Adhesin and Invasin
- (2010) Yaoping Liu et al. EUKARYOTIC CELL
- Candida albicans Dampens Host Defense by Downregulating IL-17 Production
- (2010) S.-C. Cheng et al. JOURNAL OF IMMUNOLOGY
- Hyr1 Protein and β‐Glucan Conjugates as Anti‐CandidaVaccines
- (2010) Antonio Cassone et al. JOURNAL OF INFECTIOUS DISEASES
- Candida albicansHyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target
- (2010) Guanpingsheng Luo et al. JOURNAL OF INFECTIOUS DISEASES
- Interactions between Bordetella pertussis and the complement inhibitor factor H
- (2010) Hanne Amdahl et al. MOLECULAR IMMUNOLOGY
- Beta-glucan-CRM197 conjugates as candidates antifungal vaccines
- (2010) Carla Bromuro et al. VACCINE
- Universal Vaccines: Shifting to One for Many
- (2010) A. Cassone et al. mBio
- Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis
- (2009) S. P. Saville et al. Clinical and Vaccine Immunology
- Bordetella pertussisand Pertussis Vaccines
- (2009) Nicole Guiso CLINICAL INFECTIOUS DISEASES
- IL-17/Th17 in anti-fungal immunity: What's new?
- (2009) Teresa Zelante et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The yeast Candida albicans evades human complement attack by secretion of aspartic proteases
- (2009) Katharina Gropp et al. MOLECULAR IMMUNOLOGY
- Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
- (2009) Antonella Torosantucci et al. PLoS One
- Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
- (2009) Lin Lin et al. PLoS Pathogens
- Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
- (2008) Armêl Plaine et al. FUNGAL GENETICS AND BIOLOGY
- Antibody Titer Threshold Predicts Anti‐Candidal Vaccine Efficacy Even though the Mechanism of Protection Is Induction of Cell‐Mediated Immunity
- (2008) Brad Spellberg et al. JOURNAL OF INFECTIOUS DISEASES
- Fungal vaccines: real progress from real challenges
- (2008) Antonio Cassone LANCET INFECTIOUS DISEASES
- Candida albicanscell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance
- (2008) Ingrid E. Frohner et al. MOLECULAR MICROBIOLOGY
- Synthetic glycopeptide vaccines combining -mannan and peptide epitopes induce protection against candidiasis
- (2008) H. Xin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now